These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 27788476)
1. Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients. Fang C; Wang FB; Li Y; Zeng XT Biomed Pharmacother; 2016 Dec; 84():1189-1193. PubMed ID: 27788476 [TBL] [Abstract][Full Text] [Related]
2. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma. Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062 [TBL] [Abstract][Full Text] [Related]
3. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2. Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808 [TBL] [Abstract][Full Text] [Related]
4. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766 [TBL] [Abstract][Full Text] [Related]
5. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer. Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306 [TBL] [Abstract][Full Text] [Related]
6. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer. Dong LL; Chen LM; Wang WM; Zhang LM Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779 [TBL] [Abstract][Full Text] [Related]
7. Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis. Gong L; Wang C; Gao Y; Wang J Biomed Pharmacother; 2016 Oct; 83():58-63. PubMed ID: 27470550 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer. Zhang J; Kong X; Shi Q; Zhao B Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982 [TBL] [Abstract][Full Text] [Related]
9. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features. Wang B; Li J; Sun M; Sun L; Zhang X IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313 [TBL] [Abstract][Full Text] [Related]
10. Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer. Jing LL; Mo XM Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1516-20. PubMed ID: 27160123 [TBL] [Abstract][Full Text] [Related]
11. [miR-199b-5p inhibits proliferation and invasion of head and neck cancer cells]. Wang X; Li GH; Guo J; Sun Q Shanghai Kou Qiang Yi Xue; 2018 Jun; 27(3):265-269. PubMed ID: 30411121 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling. Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of oxidized low-density lipoprotein receptor 1 correlates with decreased miR-106b-5p, miR-93-5p, miR-3129-5p, miR-199b-3p, and miR-4465, higher recurrence rate, and poor prognosis in ovarian cancer. Liu J; Zeng Y; Zheng L Histol Histopathol; 2023 Apr; 38(4):475-485. PubMed ID: 36264049 [TBL] [Abstract][Full Text] [Related]
14. Expression and change of miR-199b-5p, s HLA-G in thyroid carcinoma. Tan B; Guo J; Wang L; Wang L; Gan X; Chen B Exp Mol Pathol; 2021 Jun; 120():104643. PubMed ID: 33932399 [TBL] [Abstract][Full Text] [Related]
15. MiR-199b-5p targets HER2 in breast cancer cells. Fang C; Zhao Y; Guo B J Cell Biochem; 2013 Jul; 114(7):1457-63. PubMed ID: 23296799 [TBL] [Abstract][Full Text] [Related]
16. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer. Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730 [TBL] [Abstract][Full Text] [Related]
17. Oncogenic potential of TSTA3 in breast cancer and its regulation by the tumor suppressors miR-125a-5p and miR-125b. Sun Y; Liu X; Zhang Q; Mao X; Feng L; Su P; Chen H; Guo Y; Jin F Tumour Biol; 2016 Apr; 37(4):4963-72. PubMed ID: 26531722 [TBL] [Abstract][Full Text] [Related]
18. [Correlation of miR-195 with invasiveness and prognosis of breast cancer]. Song CG; Wu XY; Wang C; Fu FM; Shao ZM Zhonghua Wai Ke Za Zhi; 2012 Apr; 50(4):353-6. PubMed ID: 22800791 [TBL] [Abstract][Full Text] [Related]
19. miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer. Zhang J; Zhu Z; Sheng J; Yu Z; Yao B; Huang K; Zhou L; Qiu Z; Huang C Oncotarget; 2017 May; 8(21):34867-34883. PubMed ID: 28432273 [TBL] [Abstract][Full Text] [Related]
20. Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/β-catenin signaling in breast cancer. Zeng B; Li Y; Feng Y; Lu M; Yuan H; Yi Z; Wu Y; Xiang T; Li H; Ren G Biochem Biophys Res Commun; 2018 Oct; 505(1):302-308. PubMed ID: 30249392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]